Keyphrases
Acitretin
16%
Area Index
16%
Between-group
33%
Clinical Benefit
16%
Clinical Trials
16%
Clinical Visit
16%
Close Monitoring
16%
Confidence Interval
33%
Dermatologist
50%
Dermatology Life Quality Index
33%
Health Consultation
100%
High Quality of Life
16%
Methotrexate
16%
Moderate-to-severe Psoriasis
16%
Multicenter Randomized Controlled Trial
16%
Number of Trials
16%
Outpatient Clinic
16%
Patient Adherence
33%
Patient Report
16%
Patient Safety
16%
Patient Satisfaction
16%
Patient-initiated
100%
Psoriasis
100%
Psoriasis Severity
16%
Randomized Controlled Trial
100%
Routine Care
33%
Safety Patient
16%
Satisfaction with Care
33%
Severity Index
16%
Systemic Treatment
50%
Treatment Monitoring
16%
Zero Harm
16%
Medicine and Dentistry
Biological Product
33%
Clinical Trial
33%
Dermatology
33%
Dermatology Life Quality Index
66%
Etretin
33%
Methotrexate
33%
Outpatient
33%
Patient Compliance
66%
Patient Monitoring
33%
Patient Satisfaction
33%
Psoriasis
100%
Psoriasis Area and Severity Index
33%
Quality of Life
33%
Randomized Controlled Trial
100%
Systemic Therapy
100%
Nursing and Health Professions
Biological Product
33%
Confidence Interval
66%
Dermatologist
100%
Dermatology Life Quality Index
66%
Methotrexate
33%
Outpatient Department
33%
Patient Compliance
66%
Patient Monitoring
33%
Psoriasis
100%
Quality of Life
33%
Systemic Therapy
100%